Biotechnology Research in Luxembourg

Eurofins

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over staff across a network of independent companies in 59 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

10001+ staff

Probiotic Group

Probiotic Group is a biotechnology laboratory specializing in microbiology, home to the Provilan brand, offering cleaning and care solutions based on probiotics. Provilan stands out with its innovative and environmentally friendly products, incorporating beneficial microorganisms into the field of cleaning and care, thereby ensuring consumers effective and safe cleaning. Feel free to visit the Provilan brand website :

11 to 50 staff

Biorock France

Fondée en 1988, BIOROCK est une société reconnue pour son expertise du traitement des eaux usées domestiques par le filtre compact. Elle possède une vision globale de son métier : du développement de ses produits en interne jusqu’à l’extension de son réseau de vente à l’international. Au cours des 25 dernières années, BIOROCK a mis en œuvre avec succès des projets réalisés dans le monde entier. La gamme de solutions agréées pour l’assainissement non collectif (ANC) peut être utilisée pour traiter les eaux usées d’une habitation individuelle, mais aussi de restaurants, hôtels, campings, institutions (écoles, salles des fêtes, etc.), centres commerciaux, et autres bâtiments.

51 to 200 staff

Mitotech

A clinical-stage biotechnology company based in the UK and Luxembourg, developing next-generation therapies for obesity and cardiometabolic disorders based on novel class of small molecules accelerationg energy expenditure.

1 to 10 staff

Moolec Science

We are a science-based ingredient company leader in the use of Molecular Farming technology for food and dietary supplementation markets. Our mission is to create unique food ingredients by engineering plants with animal protein genes. Moolec’s technological approach aims to have the cost structure of plant-based solutions with the nutrition and functionality of animal-based ones. Our technology has been under development for more than a decade and is known for pioneering the production of a bovine protein in a crop for the food industry. The Company’s product portfolio and pipeline leverages the agronomic efficiency of broadly used target crops, like soybean, pea, and safflower to produce oils and proteins. Moolec has an industrial and commercial R&D capability to complement the company’s Molecular Farming technology. The company secures a growing international patent portfolio (25+, both granted and pending) for both products and technology. Moolec is run by a diverse, highly qualified, and experienced team of Ph.Ds and Food insiders, and operates in the United States, Europe, and South America. In early 2023, we became the first Molecular Farming food-tech company to trade in public markets in the Nasdaq Stock Market under the ticker "MLEC". Let’s redefine the way we produce animal protein for the good of the planet! Welcome to Moolec Science.

11 to 50 staff

Exobiosphere

The world's first space focused pre-clinical contract research organization. Our mission is to extend and improve life on Earth and in Space. We use microgravity as a new dimension for biology to accelerate drug discovery and unlock therapies that are very hard or even impossible to develop on Earth. We’re building the world’s first standardized space-based high-throughput testing platform, allowing pharma and biotech partners to run automated experiments in orbit, at scale. By combining microgravity with advanced lab automation and bioinformatics, we create more physiologically relevant models, observe faster disease development, and reach enhanced 3D biology compared to standard in-vitro systems. The goal is simple: make space a routine, essential part of the biomedical R&D pipeline so we can bring better and faster treatments to patients.

11 to 50 staff

Invitrolize

Our in vitro model allows for the first time the identification and differentiation of respiratory sensitizers and respiratory irritants under air-liquid interphase realistic exposure conditions.

1 to 10 staff

House Of Biohealth

Description 0 used out of maximum characters. Une description est requise. The Project House of Biohealth – ICT – Cleantech – next generation is a new concept designed to stimulate Innovation in these major sectors. It is more than a building, it is an Innovation accelerator meant to regroup in one area young, dynamic and creative entrepreneurs in an inspiring atmosphere where internal communication between tenants is specially pushed. Perhaps these lines will have raised your interest and you want to get more information:

1 to 10 staff

Megeno

Megeno is a Luxembourg-based life sciences company that provides preventive health solutions for individuals, organisations, and healthcare communities. Our smart, personalised solutions are built upon aggregate, long term healthcare data regarding the biology and lifestyle of the individual. We believe that this aggregated data may serve as a prerequisite for efficient health management and may become a lifetime asset for the individual - an asset one can reference, transfer, reuse, add to, and share throughout a lifetime of healthcare decisions. We are committed to being your trusted intermediary in data governance and in parallel, their data steward for a lifetime.

11 to 50 staff

Usil Therapeutics S.A

OUR MISSION: Protecting Lives Against Radiation Threats. USIL Therapeutics pioneers breakthrough medical solutions to safeguard people from the dangers of ionizing radiation. Our mission is to transform radiation defense with treatments and potential cures that go beyond symptomatic care, delivering true whole-body protection. Partnering with governments, defense, and energy sectors worldwide, we provide scalable, effective countermeasures that strengthen resilience and global preparedness in the face of nuclear and radiological risks.

11 to 50 staff

Poly Diagnostics

We are committed to deliver best-in-class quality and performance products for our customers. Our goal is to provide innovative molecular reagents for better diagnostics, biotechnology and life science research. At Poly Diagnostics, we use our technical expertise to develop virus-like particles, nucleic acid extraction kits, enzymes and innovative in vitro nucleic acid amplification diagnostic products in a unique dry format. The technology allows our clients to save up to 80% time on testing. A clinical sample can be added directly to a test tube containing all the dried reagents. Our dry diagnostic products are stored at room temperature for 24 months - saving costs on equipment and energy. A truly revolutionizing technology not only for diagnostic laboratories but also for point-of-care settings. We are your trusted partner in molecular diagnostics and life sciences!

1 to 10 staff

Nada

Nada is a cleantech circular materials company transforming agricultural side-streams into high-performance bio-based oils and functional ingredients through advanced green extraction and bioprocess optimization. By partnering with the packaging industry, farming cooperatives, and juicing companies in Peru and the EU, we connect existing supply chains with industrial demand, ensuring both sustainability and scalability. Currently upcycling: pomegranate, avocado, orange, and microalgae. Curious? Let’s talk.

1 to 10 staff

Organotherapeutics

OrganoTherapeutics uses cutting-edge human-specific midbrain organoids for the discovery and development of effective drug candidates targeting Parkinson’s disease. We screen new molecules on our proprietary organoids which mimic faithfully the human Parkinson’s disease pathology. OrganoTherapeutics aims at developing new drug candidates against Parkinson’s disease which are tested in state-of-the art 3D patient models. OrganoTherapeutics has developed first own proprietary drug candidates and has access to attractive libraries for further screening.

1 to 10 staff

Mbd Medical & Bio Decision

New 3D Cell Culture and Organoid-Based High-Throughput Drug Screening Solution for New Drug Discovery and Personalized Precision Medicine MBD (Medical & Bio Decision) is focused on technologies supporting new drug development and personalized precision medicine by the development of organoid-based drug screening and utilizing of 3D cell culture. MBD has developed a unique, fully automated HTS (high-throughput screening) Platform for hospitals and advanced medical clinics for identifying the most effective treatment to each individual. The process results in predicting the most effective treatment both fast and with high accuracy. The company has conducted clinical trials on many cancer types (lung, ovarian, stomach, head/neck cancer, esophageal cancers) and will soon expand the technology to apply also to prostate, colo, and pancreatic cancers. Founded originally in 2015 in South Korea, the company has grown into a succesful international medtech company with activities in Asia and USA and is currently growing actively in Europe. MBD has secured the following international standards- CE Marking for the European market - FDA clearance for the United States - ISO 13485:2016 – Quality management for medical devices - ISO/TC 229-TR 22455 – Nanotechnologies and advanced materials standards

11 to 50 staff

Blue Horizon Sàrl

1 to 10 staff